ABRAXANE (Abraxis BioScience, LLC)


Welcome to the PulseAid listing for the ABRAXANE drug offered from Abraxis BioScience, LLC. This Microtubule Inhibition [PE],Microtubule Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Abraxis BioScience, LLC
NON-PROPRIETARY NAME: Paclitaxel
SUBSTANCE NAME: PACLITAXEL
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Microtubule Inhibition [PE],Microtubule Inhibitor [EPC]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2005-02-10
END MARKETING DATE: 0000-00-00


ABRAXANE HUMAN PRESCRIPTION DRUG Details:

Item DescriptionABRAXANE from Abraxis BioScience, LLC
LABELER NAME: Abraxis BioScience, LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 100(mg/20mL)
START MARKETING DATE: 2005-02-10
END MARKETING DATE: 0000-00-00
PRODUCT ID: 68817-134_8b78c8ab-6766-4120-8213-eaa30731d3e4
PRODUCT NDC: 68817-134
APPLICATION NUMBER: NDA021660

Other PACLITAXEL Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Abraxis BioScience, LLCABRAXANE
Actavis Pharma, Inc.Paclitaxel
Athenex Pharmaceutical Division, LLC.Paclitaxel
Breckenridge Pharmaceutical, Inc.Paclitaxel
Fresenius Kabi USA, LLCPaclitaxel
Gland Pharma LimitedPACLITAXEL
Hospira, Inc.Paclitaxel
Mylan Institutional LLCPaclitaxel
Pfizer Laboratories Div Pfizer Inc.paclitaxel
Sagent PharmaceuticalsPaclitaxel
Sandoz IncPaclitaxel
Teva Parenteral Medicines, Inc.Paclitaxel
WG Critical Care, LLCPaclitaxel